Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Okamoto, Hiroshi ^a,b   Kobayashi, Akiko ^a,b   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Minami Otsuka Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; AUTOANTIBODY;

AUTOIMMUNE DISEASE; BRAIN; CEREBROSPINAL FLUID; ELECTROENCEPHALOGRAM; HUMAN; LUMBAR PUNCTURE; MENINGITIS; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; BRAIN VASCULITIS; METABOLISM; PATHOPHYSIOLOGY;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CYTOKINES; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 77955369334     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/268436     Document Type: Review

References (50)

1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature Arthritis and Rheumatism 1999 42 4 599 608
2. Bresnihan B., CNS lupus Clinics in Rheumatic Diseases 1982 8 1 183 195
3. Brey R. L., Holliday S. L., Saklad A. R., Navarrete M. G., Hermosillo-Romo D., Stallworth C. L., Valdez C. R., Escalante A., Del Rincn I., Gronseth G., Rhine C. B., Padilla P., McGlasson D., Neuropsychiatric syndromes in lupus: prevalence using standardized definitions Neurology 2002 58 8 1214 1220
4. Ainiala H., Loukkola J., Peltola J., Korpela M., Hietaharju A., The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus Neurology 2001 57 3 496 500 (Pubitemid 32757599)
5. Trysberg E., Carlsten H., Tarkowski A., Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement Lupus 2000 9 7 498 503
6. Svenungsson E., Andersson M., Brundin L., Van Vollenhoven R., Khademi M., Tarkowski A., Greitz D., Dahlstrm M., Lundberg I., Klareskog L., Olsson T., Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus Annals of the Rheumatic Diseases 2001 60 4 372 379
7. Iikuni N., Okamoto H., Yoshio T., Sato E., Kamitsuji S., Iwamoto T., Momohara S., Taniguchi A., Yamanaka H., Minota S., Kamatani N., Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus Annals of the Rheumatic Diseases 2006 65 2 253 256
8. Okamoto H., Iikuni N., Kamitsuji S., Yoshio T., Minota S., Kamatani N., IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients Rheumatology 2006 45 2 232 234
9. Okamoto H., Katsumata Y., Nishimura K., Kamatani N., Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus Arthritis and Rheumatism 2004 50 11 3731 3732
10. Aringer M., Graninger W. B., Steiner G., Smolen J. S., Safety and efficacy of tumor necrosis factor blockade in systemic lupus erythematosus: an open-label study Arthritis and Rheumatism 2004 50 10 3161 3169
11. Rahman A., Isenberg D. A., Systemic lupus erythematosus New England Journal of Medicine 2008 358 9 929 939
12. Alcocer-Varela J., Aleman-Hoey D., Alarcon-Segovia D., Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers Lupus 1992 1 2 111 117
13. Gilad R., Lampl Y., Eshel Y., Barak V., Sarova-Pinhas I., Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus British Journal of Rheumatology 1997 36 2 190 193
14. Jönsen A., Bengtsson A. A., Nived O., Ryberg B., Truedsson L., Rnnblom L., Alms G. V., Sturfelt G., The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles Lupus 2003 12 11 846 850
15. Jara L. J., Irigoyen L., De Ortiz M. J., Zazueta B., Bravo G., Espinoza L. R., Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus Clinical Rheumatology 1998 17 2 110 114
16. Hirohata S., Miyamoto T., Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement Arthritis and Rheumatism 1990 33 5 644 649
17. Hirohata S., Hayakawa K., Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus Arthritis and Rheumatism 1999 42 12 2729 2730
18. Tsai C.-Y., Wu T.-H., Tsai S.-T., Chen K.-H., Thajeb P., Lin W.-M., Yu H.-S., Yu C.-L., Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections Scandinavian Journal of Rheumatology 1994 23 2 57 63
19. Trysberg E., Carlsten H., Tarkowski A., Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement Lupus 2000 9 7 498 503
20. Dellalibera-Joviliano R., Dos Reis M. L., Cunha F. D. Q., Donadi E. A., Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus Journal of Rheumatology 2003 30 3 485 492
21. Fragoso-Loyo H., Richaud-Patin Y., Orozco-Narväez A., Dvila-Maldonado L., Atisha-Fregoso Y., Llorente L., Snchez-Guerrero J., Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus Arthritis and Rheumatism 2007 56 4 1242 1250 (Pubitemid 46608649)
22. Santer D. M., Yoshio T., Minota S., Möller T., Elkon K. B., Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus Journal of Immunology 2009 182 2 1192 1201
23. Gilad R., Lampl Y., Eshel Y., Barak V., Sarova-Pinhas I., Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus British Journal of Rheumatology 1997 36 2 190 193
24. Winfield J. B., Shaw M., Silverman L. M., Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction American Journal of Medicine 1983 74 5 837 844
25. Shiozawa S., Kuroki Y., Kim M., Hirohata S., Ogino T., Interferon-alpha in lupus psychosis Arthritis and Rheumatism 1992 35 4 417 422
26. Hirohata S., Kanai Y., Mitsuo A., Tokano Y., Hashimoto H., Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. NPSLE Research Subcommittee Clinical Rheumatology 2009 28 11 1319 1323
27. George-Chandy A., Trysberg E., Eriksson K., Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms Arthritis Research and Therapy 2008 10 4, article R97
28. Katsumata Y., Harigai M., Kawaguchi Y., Fukasawa C., Soejima M., Takagi K., Tanaka M., Ichida H., Tochimoto A., Kanno T., Nishimura K., Kamatani N., Hara M., Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-α, IgG index, and Q-albumin Journal of Rheumatology 2007 34 10 2010 2017
29. Yoshio T., Yamazaki S., Okamoto H., IgG anti-NR2 glutamate receptor antibodies (anti-NR2) from patients with systemic lupus erythematosus (SLE) as causative auto-antibodies of damage to the blood-brain barrier (BBB) Proceedings of the ACR Annual Scientific Meeting 2009
30. Charo I. F., Ransohoff R. M., Mechanisms of disease: the many roles of chemokines and chemokine receptors in inflammation New England Journal of Medicine 2006 354 6 610 621
31. Iwamoto T., Okamoto H., Toyama Y., Momohara S., Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients FEBS Journal 2008 275 18 4448 4455
32. Luster A. D., Mechanisms of disease: chemokineschemotactic cytokines that mediate inflammation New England Journal of Medicine 1998 338 7 436 445
33. Kelner G. S., Kennedy J., Bacon K. B., Kleyensteuber S., Largaespada D. A., Jenkins N. A., Copeland N. G., Bazan J. F., Moore K. W., Schall T. J., Zlotnik A., Lymphotactin: a cytokine that represents a new class of chemokine Science 1994 266 5189 1395 1399
34. Bazan J. F., Bacon K. B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D. R., Zlotnik A., Schall T. J., A new class of membrane-bound chemokine with a CX3C motif Nature 1997 385 6617 640 642 (Pubitemid 27087578)
35. Zlotnik A., Yoshie O., Chemokines: a new classification system and their role in immunity Immunity 2000 12 2 121 127
36. Bacon K., Baggiolini M., Broxmeyer H., Chemokine/chemokine receptor nomenclature Journal of Interferon & Cytokine Research 2002 22 1067 1068
37. + T lymphocytes FASEB Journal 1994 8 13 1055 1060
38. Schall T. J., Bacon K., Toy K. J., Goeddel D. V., Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES Nature 1990 347 6294 669 671
39. Vierboom M. P. M., Zavodny P. J., Chou C.-C., Tagat J. R., Pugliese-Sivo C., Strizki J., Steensma R. W., McCombie S. W., elebi-Paul L., Remarque E., Jonker M., Narula S. K., Thart B., Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5 Arthritis and Rheumatism 2005 52 2 627 636
40. Okamoto H., Kamatani N., A CCR-5 antagonist inhibits the development of adjuvant arthritis in rats Rheumatology 2006 45 2 230 232
41. Moser B., Loetscher P., Lymphocyte traffic control by chemokines Nature Immunology 2001 2 2 123 128
42. Baggiolini M., Walz A., Kunkel S. L., Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils Journal of Clinical Investigation 1989 84 4 1045 1049
43. Trysberg E., Nylen K., Rosengren L. E., Tarkowski A., Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement Arthritis and Rheumatism 2003 48 10 2881 2887
44. Bromley S. K., Mempel T. R., Luster A. D., Orchestrating the orchestrators: chemokines in control of T cell traffic Nature Immunology 2008 9 9 970 980
45. Yajima N., Kasama T., Isozaki T., Odai T., Matsunawa M., Negishi M., Ide H., Kameoka Y., Hirohata S., Adachi M., Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations Arthritis and Rheumatism 2005 52 6 1670 1675
46. Sato E., Iikuni N., Yoshio T., Minota S., Kamatani N., Okamoto H., Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus Annals of the Rheumatic Diseases 2006 65 9 1257 1259
47. Stievano L., Piovan E., Amadori A., C and CX3C chemokines: cell sources and physiopathological implications Critical Reviews in Immunology 2004 24 3 205 228
48. Murphy G., Caplice N., Molloy M., Fractalkine in rheumatoid arthritis: a review to date Rheumatology 2008 47 10 1446 1451
49. Sato W., Aranami T., Yamamura T., Cutting edge: human Th17 cells are identified as bearing CCR2+ CCR5- phenotype Journal of Immunology 2007 178 12 7525 7529
50. Okamoto H., Cujec T. P., Yamanaka H., Kamatani N., Molecular aspects of rheumatoid arthritis: role of transcription factors FEBS Journal 2008 275 18 4463 4470